People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vektor Medical, Inc. | — | Biotechnology | Series B | $32.9M | $245.9M | 2018 |
Robert J. Krummen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert J. Krummen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| C. David Adair | 1 | 4 |
| Joe S. Braidwood | 1 | 1 |
| Lana S. Caron | 1 | 1 |
| Shannon David St. Clair | 1 | 1 |
| Chris S. Villongco | 1 | 1 |
| Luc S. Marengere | 1 | 1 |
| Douglas S. Komen | 1 | 1 |
| Alexander M. Monko | 1 | 1 |
| Kalle J. Marsal | 1 | 1 |
| Alexander Michael Monko | 1 | 1 |
| Chris J. Villongco | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.